Evolving Use of Oral PrEP (Lessons Learned) and Update on New Prevention Technologies – Rings, Long-acting Injectables, Implants - Sinead Delany-Moretlwe, MBBCh, PhD, DTM&H

INTEREST 2019

Global Burden and Novel Treatment of Noroviruses | Ladislau Kovari, PhD

HIV DART and Emerging Viruses 2016

Invited lecture: What is happening in Latin America (Brazil, Colombia, etc.) - David Kershenobich Stalnikowitz, MD, PhD

Latin American Meeting on Treatment of Viral Hepatitis and HIV Co-infection 2015

What is the Pharmacological support for reduce drug regimens? | David Back, PhD

Global HIV Clinical Forum 2018

European HIV Clinical Forum 2023 Program Book

HPV and Cervical Anal Cancer in Women with HIV.pdf

International Workshop on HIV & Women 2024

Use of INSTI in Patients With Comorbidities and Polypharmacy - Marta Boffito, MD, PhD, FRCP

Salvador HIV Clinical Forum 2021

Pharmacokinetics of atazanavir boosted with cobicistat during pregnancy and postpartum - Jeremiah Momper

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

Hepatitis C | Ching-lung Lai, MD, FRCP, FRACP

APACC 2016

Defining the gold standard in Biomarker Validation in NAFLD | Arun Sanyal, MD, MBBS

International Workshop on NASH Biomarkers 2016